Skip to search formSkip to main contentSkip to account menu

AN-1792

Known as: AN1792, an 1792 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Amyloid beta-Peptides

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2013
Review
2013
[Aβ immunotherapy for Alzheimer's disease].
Alzheimer's disease (AD) is one of the neurodegenerative diseases characterized by the deposition of amyloid-β-protein (Aβ) as… 
Review
2011
Review
2011
[Current trend of immunotherapy for Alzheimer's disease].
Immunotherapy targeting amyloidbeta (Abeta) for Alzheimer's disease (AD) has been developed based on the amyloid cascade… 
2007
2007
Absence of (cid:1) -Amyloid Deposits After Immunization in Alzheimer Disease With Lewy Body Dementia
Objective : To describe the neuropathological and bio-chemical findings of the brain examination of a patient enrolled in the AN… 
2007
2007
AN ALTERNATIVE METHOD FOR ESTIMATING EFFICACY OF THE AN1792 VACCINE FOR ALZHEIMER DISEASE
Koepsell et al.1 suggest an alternative method for analyzing the phase 2a AN1792 studies.2,3 The original analysis compared… 
2006
2006
Can the immune system fight Alzheimer disease?
Mobilizing the immune system may be a promising strategy to fight Alzheimer disease. A clinical trial has shed light on the… 
Review
2005
Review
2005
[Abeta vaccine therapy for Alzheimer's disease].
In 1999, Schenk et al reported that vaccination of PDAPP-transgenic mice with synthetic Abeta42 in complete Freund's adjuvant… 
2004
2004
Characteristics of COX2 inhibitors questioned
A health watchdog agency's decision on COX2 inhibitors highlights the difference in opinion about the use of these treatments. 
2004
2004
Vaccine approach for Alzheimer's disease revisited
A follow-up of the patients that took part in a halted Alzheimer's vaccine trial indicates that it might have provided benefit in… 
2002
2002
Toxicity of β‐amyloid vaccination in patients with Alzheimer's disease
On January 18, 2002, Elan Corporation and American Home Products reported their decision to temporarily suspend dosing in a phase… 
2001
2001
AN-1792: A Frank Revolution?
Will AN-1792, the “vaccine against Alzheimer's,” gain the same significance for the aging human brain as the year 1792 for… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)